zaleplon and its Impurities
Zaleplon is used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon, sold under the brand names Sonata.Reference standards of Zaleplon API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
 
	
			                                  ![N-(3-(3-(4-Amino-2H-pyrazolo[3,4-d]pyrimidin-6-yl) PA 26 02510](https://www.pharmaffiliates.com/pimages/PA2602510.jpg) 
																				N-(3-(3-(4-Amino-2H-pyrazolo[3,4-d]pyrimidin-6-yl)pyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide
N-(3-(3-(4-Amino-2H-pyrazolo[3,4-d]pyrimidin-6-yl)pyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide
- Catalogue No.:PA 26 02510 
- CAS : - 940951-52-0
- Molecular Formula : C21H19N9O 
- Molecular Weight : 413.44 
 
	
			                                   
																				(E)-N-(3-(3-Cyano-6-(3-(3-(N-ethylacetamido)phenyl)-3-oxoprop-1-en-1-yl)pyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide
(E)-N-(3-(3-Cyano-6-(3-(3-(N-ethylacetamido)phenyl)-3-oxoprop-1-en-1-yl)pyrazolo[1,5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide
- Catalogue No.:PA 26 02520 
- CAS : - 940951-61-1
- Molecular Formula : C30H28N6O3 
- Molecular Weight : 520.58 
 
	
			                                   
																				Zaleplon Related Compound B (N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamid (1724372)
Zaleplon Related Compound B (N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamid (1724372)
- Catalogue No.:PA USP1724372 
- CAS : - NA
- Molecular Formula : NA 
- Molecular Weight : NA 
 
	
			                                   
																				Zaleplon Related Compound C (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide) (1724383)
Zaleplon Related Compound C (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide) (1724383)
- Catalogue No.:PA USP1724383 
- CAS : - 940951-54-2
- Molecular Formula : NA 
- Molecular Weight : NA 

 
																				![N-[3-(3-Dimethylaminoacryloyl)phenyl]-N-ethylaceta PA STI 033530](https://www.pharmaffiliates.com/pimages/PASTI033530.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![N-[3-[3-(Dimethylamino)-1-oxo-2-propenyl]phenyl]-N PA 26 0021000](https://www.pharmaffiliates.com/pimages/PA260021000.jpg) 
																				![N-(3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl) PA 26 0021001](https://www.pharmaffiliates.com/pimages/PA260021001.jpg) 
																				![N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]p PA 26 0021002](https://www.pharmaffiliates.com/pimages/PA260021002.jpg) 
																				 
																				![N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]p PA 26 0021003](https://www.pharmaffiliates.com/pimages/PA260021003.jpg) 
																				 
																				 
																				![N-(3-(3-Cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl) PA 26 0021006](https://www.pharmaffiliates.com/pimages/PA260021006.jpg) 
																				 
																				 
																				![7-[3-(Acetylethylamino)phenyl]pyrazolo[1,5-a]pyrim PA 26 0021010](https://www.pharmaffiliates.com/pimages/PA260021010.jpg) 
																				 
 
 
 
